Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2
- PMID: 12778114
- DOI: 10.1038/nsb936
Structural basis for negative regulation of hypoxia-inducible factor-1alpha by CITED2
Abstract
Expression of hypoxia-responsive genes is mediated by the heterodimeric transcription factor hypoxia-inducible factor-1 (HIF-1) in complex with the p300/CREB-binding protein (p300/CBP) transcriptional coactivator. The protein CITED2, which binds p300/CBP, is thought to be a negative regulator of HIF-1 transactivation. We show that the CITED2 transactivation domain (TAD) disrupts a complex of the HIF-1alpha C-terminal TAD (C-TAD) and the cysteine-histidine-rich 1 (CH1) domain of p300/CBP by binding CH1 with high affinity. The high-resolution solution structure of the CITED2 TAD-p300 CH1 complex shows that the CITED2 TAD, like the HIF-1alpha C-TAD, folds on a helical, Zn2+-containing CH1 scaffold. The CITED2 TAD binds a different, more extensive surface of CH1 than does the HIF-1alpha C-TAD. However, a conserved 'LPXL' sequence motif in CITED2 and HIF-1alpha interacts with an overlapping binding site on CH1. Mutation of the LPEL sequence in full-length CITED2 abolishes p300 binding in vivo. These findings reveal that CITED2 regulates HIF-1 by competing for a hot spot on the p300 CH1 domain.
Comment in
-
ExCITED about HIF.Nat Struct Biol. 2003 Jul;10(7):501-3. doi: 10.1038/nsb0703-501. Nat Struct Biol. 2003. PMID: 12825087 No abstract available.
Similar articles
-
Three conformational states of the p300 CH1 domain define its functional properties.Biochemistry. 2003 Aug 26;42(33):9937-45. doi: 10.1021/bi034989o. Biochemistry. 2003. PMID: 12924942
-
CITED4 inhibits hypoxia-activated transcription in cancer cells, and its cytoplasmic location in breast cancer is associated with elevated expression of tumor cell hypoxia-inducible factor 1alpha.Cancer Res. 2004 Sep 1;64(17):6075-81. doi: 10.1158/0008-5472.CAN-04-0708. Cancer Res. 2004. PMID: 15342390
-
Partial rescue of defects in Cited2-deficient embryos by HIF-1alpha heterozygosity.Dev Biol. 2007 Jan 1;301(1):130-40. doi: 10.1016/j.ydbio.2006.08.072. Epub 2006 Sep 12. Dev Biol. 2007. PMID: 17022961
-
CITED2 and the modulation of the hypoxic response in cancer.World J Clin Oncol. 2020 May 24;11(5):260-274. doi: 10.5306/wjco.v11.i5.260. World J Clin Oncol. 2020. PMID: 32728529 Free PMC article. Review.
-
Recent Advances in the Discovery of HIF-1α-p300/CBP Inhibitors as Anti-Cancer Agents.Mini Rev Med Chem. 2018;18(4):296-309. doi: 10.2174/1389557516666160630124938. Mini Rev Med Chem. 2018. PMID: 27484627 Review.
Cited by
-
Hypoxia and the hypoxia-inducible-factor pathway in glioma growth and angiogenesis.Neuro Oncol. 2005 Apr;7(2):134-53. doi: 10.1215/S1152851704001115. Neuro Oncol. 2005. PMID: 15831232 Free PMC article. Review.
-
Lysine acetyltransferases and lysine deacetylases as targets for cardiovascular disease.Nat Rev Cardiol. 2020 Feb;17(2):96-115. doi: 10.1038/s41569-019-0235-9. Epub 2019 Jul 26. Nat Rev Cardiol. 2020. PMID: 31350538 Review.
-
Structural basis for recruitment of CBP/p300 coactivators by STAT1 and STAT2 transactivation domains.EMBO J. 2009 Apr 8;28(7):948-58. doi: 10.1038/emboj.2009.30. Epub 2009 Feb 12. EMBO J. 2009. PMID: 19214187 Free PMC article.
-
Transcriptional regulation by hypoxia inducible factors.Crit Rev Biochem Mol Biol. 2014 Jan-Feb;49(1):1-15. doi: 10.3109/10409238.2013.838205. Epub 2013 Oct 7. Crit Rev Biochem Mol Biol. 2014. PMID: 24099156 Free PMC article. Review.
-
Role of Intrinsic Protein Disorder in the Function and Interactions of the Transcriptional Coactivators CREB-binding Protein (CBP) and p300.J Biol Chem. 2016 Mar 25;291(13):6714-22. doi: 10.1074/jbc.R115.692020. Epub 2016 Feb 5. J Biol Chem. 2016. PMID: 26851278 Free PMC article. Review.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Miscellaneous